3-氨基-2,3,6-三脱氧-L-核-六糖 | 51832-86-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-2,3,6-三脱氧-L-核-六糖
• 中文别名: N-(3-皮考基)-3,5-二甲基苯甲酰胺
• 英文名称: N-(3-Picolyl)-3,5-dimethylbenzamid
• 英文别名: 3,5-dimethyl-N-pyridin-3-ylmethyl-benzamide；N-(3-Picolyl)-3,5-dimethylbenzamide；3,5-dimethyl-N-(pyridin-3-ylmethyl)benzamide
• CAS: 51832-86-1
• 化学式: C₁₅H₁₆N₂O
• 分子量: 240.305
• InChiKey: KGGOBVPLAQWHHP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

文献信息

• COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES
  申请人：Johansen Lisa M.

  公开号：US20100009970A1

  公开（公告）日：2010-01-14

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

  本发明涉及用于治疗病毒性疾病的组合物、方法和试剂盒。在某些实施方式中，病毒性疾病是由单链RNA病毒、黄病毒科病毒或肝病毒引起的。在特定实施方式中，病毒性疾病是病毒性肝炎（例如甲型肝炎、乙型肝炎、丙型肝炎、丁型肝炎、戊型肝炎），药剂或药剂组合包括舍曲林、舍曲林类似物、UK-416244或UK-416244类似物。还包括用于鉴定可用于治疗病毒性疾病的新化合物的筛选方法。
• LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE
  申请人：NISSAN CHEMICAL INDUSTRIES, LTD.

  公开号：US20160244673A1

  公开（公告）日：2016-08-25

  To provide a liquid crystal aligning agent to obtain a liquid crystal alignment film which is excellent in the adhesion to a sealing agent and in the liquid crystal alignment property. A liquid crystal aligning agent containing at least one polymer selected from the group consisting of a polyimide precursor having structural units represented by the formula (1) and structural units represented by the formula (3) and an imidized polymer of the polyimide precursor: wherein X 1 and X 4 are a tetravalent organic group, Y 1 is a bivalent organic group having a thermally-leaving group, Y 2 is a bivalent organic group, R 1 and R 2 are a hydrogen atom or a C 1-5 alkyl group, and Z 1 and Z 2 are a hydrogen atom, or a C 1-10 alkyl group, C 2-10 alkenyl group or C 2-10 alkynyl group which may have a substituent.

  提供一种液晶定向剂，以获得具有优异密封剂附着性和液晶定向性的液晶定向膜。所述液晶定向剂包含至少一种聚合物，所述聚合物从以下组中选择：具有由公式（1）和公式（3）表示的结构单元的聚酰亚胺前体和聚酰亚胺前体的缩酐聚合物：其中X1和X4是四价有机基团，Y1是具有热离基的双价有机基团，Y2是双价有机基团，R1和R2是氢原子或C1-5烷基基团，Z1和Z2是氢原子或C1-10烷基基团、C2-10烯基基团或C2-10炔基基团，可以具有取代基。
• LIQUID CRYSTAL ALIGNING AGENT CONTAINING POLYIMIDE PRECURSOR HAVING THERMALLY-LEAVING GROUP AND/OR POLYIMIDE
  申请人：NISSAN CHEMICAL INDUSTRIES, LTD.

  公开号：US20160264867A1

  公开（公告）日：2016-09-15

  To provide a liquid crystal aligning agent to obtain a liquid crystal alignment film which is excellent in the adhesion to a sealing agent and a substrate of a liquid crystal display device, and of which a decomposed product formed after irradiation with ultraviolet rays will easily be removed. A liquid crystal aligning agent containing at least one polymer selected from the group consisting of a polyimide precursor having a bond represented by the following formula (1) in its main chain and an imidized polymer of the polyimide precursor: wherein each of R 1 , R 2 , R 3 and R 4 which are independent of one another, is a hydrogen atom or a C 1-20 monovalent hydrocarbon group which may have a substituent, and D is a protecting group to be replaced with a hydrogen atom by heat.

  提供一种液晶定向剂，以获得在液晶显示器的密封剂和基板上具有优异附着性的液晶定向膜，并且在紫外线照射后形成的分解产物易于去除。该液晶定向剂包含至少一种聚合物，所述聚合物从以下群组中选择：具有其主链中表示如下式（1）的键的聚酰亚胺前体和聚酰亚胺前体的缩合聚合物：其中，R1、R2、R3和R4各自独立地是氢原子或C1-20个单价烃基，可以具有取代基，D是保护基，可通过热被氢原子取代。
• Liquid crystal display device
  申请人：NISSAN CHEMICAL INDUSTRIES, LTD.

  公开号：US11112654B2

  公开（公告）日：2021-09-07

  A liquid crystal display device, which includes a first substrate and a second substrate disposed to face each other with a liquid crystal sandwiched therebetween. The first substrate is an electrode-provided substrate having a first electrode and a plurality of second electrodes overlaid on the first electrode via an insulating film, formed on a pixel region on a surface on the liquid crystal side, where one of the first electrode and the second electrodes is a pixel electrode and the other is a counter electrode, having a first liquid crystal alignment film formed on the surface on the liquid crystal side of the first substrate covered with the second electrodes. The second substrate is a substrate having a second liquid crystal alignment film formed on a surface on the liquid crystal side, the second liquid crystal alignment film containing a photosensitive side chain type polymer which develops liquid crystallinity.

  一种液晶显示装置，它包括一个第一基板和一个第二基板，两个基板面对面，中间夹着液晶。第一基板是一种提供电极的基板，具有一个第一电极和多个第二电极，通过绝缘膜覆盖在第一电极上，形成在液晶侧表面的像素区域上，其中第一电极和第二电极中的一个是像素电极，另一个是对电极，第一基板的液晶侧表面上形成有第一液晶对准膜，覆盖有第二电极。第二基板是在液晶侧表面形成有第二液晶配向膜的基板，该第二液晶配向膜含有可形成液晶的光敏侧链型聚合物。
• Compositions and methods for treatment of viral diseases
  申请人：Johansen Lisa M.

  公开号：US20080161324A1

  公开（公告）日：2008-07-03

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.